Neurotensin-induced myocardial noradrenergic effects in spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 47, Issue 2, 2006, Pages 221-227

  Osadchii, Oleg ^a,b   Woodiwiss, Angela ^a   Deftereos, Dawn ^a   Norton, Gavin ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Hypertension; Neurotensin; Sympathetic nervous system

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NEUROPEPTIDE; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR ANTAGONIST; NORADRENALIN; PROPRANOLOL; PYRAZOLE DERIVATIVE; QUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG TARGETING; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HYPERTENSION; INOTROPISM; ISOLATED HEART; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; ADRENERGIC SYSTEM; ANIMAL; BLOOD PRESSURE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; IN VITRO STUDY; MALE; METABOLISM; PERFUSION; PHYSIOLOGY; WISTAR KYOTO RAT;

ANIMALS; ATENOLOL; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; MALE; MYOCARDIAL CONTRACTION; NEUROTENSIN; NOREPINEPHRINE; PERFUSION; PROPRANOLOL; PYRAZOLES; QUINOLINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, NEUROTENSIN; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR FUNCTION, LEFT;

EID: 33746427227     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000200988.85868.f8     Document Type: Article

References (25)

1. Agabiti-Rosei E, Muiesan ML, Romanelli G, et al. Cardiac function as related to adrenergic activity in hypertensive left ventricular hypertrophy. J Clin Hypertens. 1987;3:203-210.
2. Kelm M, Schafer S, Minger S, et al. Left ventricular mass is linked to noradrenaline in normotensive and hypertensive patients. J Hypertens. 1996;14:1365-1367.
3. Veliotes DGA, Woodiwiss AJ, Deftereos DAJ, et al. Aldosterone receptor blockade prevents the transition from compensated to decompensated cardiac hypertrophy induced by β-adrenoreceptor-activation. Hypertension. 2005;45:914-920.
4. Schlaich MP, Keye DM, Lambert E, et al. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108:560-565.
5. Badenhorst D, Veliotes D, Maseko M, et al. β-adrenergic activation initiates chamber dilatation in concentric hypertrophy. Hypertension. 2003;41:499-504.
6. Esposito G, Rapacciulo A, Prasad N, et al. Genetic alterations that inhibit in vivo pressure overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation. 2002;5:85-92.
7. Chan V, Wilson K, Burstow D, et al. Chronic β-adrenoceptor blockade prevents progression of heart failure in ageing SHR. J Mol Cell Cardiol. 2004;37:321.
8. Leineweber K, Brandt K, Wludyka B, et al. Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac β-adrenoceptor system in experimental heart failure. Circ Res. 2002;91:1056-1062.
9. Rumantir MS, Kaye DM, Jennings GL, et al. Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension. 2000;36:824-849.
10. Weihe E, Reinecke M. Peptidergic innervation of the mammalian sinus nodes: vasoactive intestinal polypeptide, neurotensin, substance P. Neurosci Lett. 1981;26:283-288.
11. Onuoha GN, Alpar EK, Chukwulobelu R, et al. Distributions of VIP, substance P, neurokinin A and neurotensin in rat heart: an immunocytochemical study. Neuropeptides. 1999;33:19-25.
12. Onuoha GN, Nicholls DP, Alpar EK, et al. Regulatory peptides in the heart and major vessels of man and mammals. Neuropeptides. 1999;33:165-172.
13. Osadchii O, Norton GR, Deftereos D, et al. Impact and mechanisms of action of neurotensin on cardiac contractility in the rat left ventricle. Eur J Pharmacol. 2005;520:108-117.
14. 2a receptor activation in rat heart. Am J Physiol. 1999;276:H341-H349.
15. Gully D, Canton M, Boigegrain R, et al. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc Natl Acad Sci USA. 1993;90:65-69.
16. Ganhao MF, Hattingh J, Hurwitz ML, et al. Evaluation of simple plasma catecholamine extraction procedure prior to high-performance liquid chromatography and electrochemical detection. J Chromatogr. 1991;564:55-66.
17. Woodiwiss AJ, Tsotetsi OJ, Sprott S, et al. Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation. 2001;103:155-160.
18. Norton GR, Woodiwiss AJ, Gaasch WH, et al. Heart failure in pressure overload hypertrophy: the relative roles of ventricular remodeling and myocardial dysfunction. J Am Coll Cardiol. 2002;39:664-671.
19. Weber KT, Janicki J, Schroff SG, et al. Collagen remodeling of the pressure-overloaded hypertrophied non-human primate myocardium. Circ Res. 1988;62:757-765.
20. Ceconi C, Condorelli E, Quinzanini M, et al. Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure. Cardiovasc Res. 1989;23:674-682.
21. Shulkes A, Lewis SJ, Jarrott B. Strain differences in central nervous system neurotensin content between normotensive and spontaneously hypertensive rats. Brain Res. 1987;415:404-408.
22. Devereux RB, Dahlof B, Gerdts E, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol. Circulation. 2004;110:1456-1462.
23. Bakris GL, Sowers JR. When does new onset diabetes resulting from antihypertensive therapy increase cardiovascular risk? Hypertension. 2004;43:941-942.
24. Nicholls DP, Riley M, Elborn JS, et al. Regulatory peptides in the plasma of patients with chronic cardiac failure at rest and during exercise. Eur Heart J. 1992;13:1399-1404.
25. 2 receptor expressed in Chinese hamster ovary cells. Eur J Pharmacol. 1998;360:265-272.